Plunkett Research Online: CTI BioPharma Corp

CTI BIOPHARMA CORP (CTIC) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

CTI BioPharma Corp is a biopharmaceutical company focused on the acquisition, development, and commercialization of less toxic and more effective cancer therapies. Its therapeutic area is blood-related cancers. Its products under the pipeline include Pacritinib. Pacritinib is an investigational oral.....


CTI BIOPHARMA CORP

Ticker: CTIC
Exchange: NAS
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 206-282-7100
Fax: 206-284-6206
Address: 3101 Western Avenue, Ste .800
Seattle, WA 98121 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Contacts Description

Adam CraigCEO/Chief Medical Officer/Director/President
David KirskeCFO/Chief Accounting Officer/Executive VP/Secretary
See More
CTI BioPharma Corp is a biopharmaceutical company focused on the acquisition, development, and commercialization of less toxic and more effective cancer therapies. Its therapeutic area is blood-related cancers. Its products under the pipeline include Pacritinib. Pacritinib is an investigational oral.....See More See More

$USD, In whole numbers2023202220212020201920182017
Sales
Profits
Brands, Divisions and Affiliates Top Salaries
Salary
Bonus
Other Thoughts Corporate Culture

CTI offers its employees a compensation and benefits package.